Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis

NCT03844061 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Systemic Sclerosis

Interventions

DRUG: Belimumab
DRUG: Rituximab
OTHER: Placebo Subcutaneous Injection
OTHER: Placebo Infusion
DRUG: MMF

Sponsor

Hospital for Special Surgery, New York

Collaborators

[object Object]